| AS1413 |
| 5-amino-2-[2-(dimethylamino)ethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione |
| (CAS 69408-81-7) |
 |
| Description： |
Amonafide (originally AS1413) (INN, trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and DNA intercalators.
It is being developed as an anti-cancer therapy by Antisoma.[1]
As of 2008, it is in Phase III clinical trials. e.g. In March 2010 it is Phase III trial against secondary acute myeloid leukaemia (AML).[2] |
| Product No. |
KT00097 |
| Product Name |
AS1413 |
| Synonyms |
Xanafide; Quinamed;Amonafide |
| Formal Name |
5-amino-2-[2-(dimethylamino)ethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione |
| CAS Number |
69408-81-7 |
| Molecular Formula |
C16H17N3O2 |
| Formula Weight |
283.33 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Amsacrine
Betulinic acid
Campathecin
Daun02
Daunorubicin
DOXO-EMCH
Doxorubicin |
|
